• LOGIN
  • SUBSCRIBE
  • REQUEST QUOTATION
LAB-A-PORTER
  • HOME
  • SUPPLIERS
  • APPLICATIONS
  • BLOG
  • FINDER
  • CAREER
  • ABOUT
  • CONTACT
Select Page
Summer 2026 LAB-A-PORTER Newsletter promotion

Summer 2026 LAB-A-PORTER Newsletter promotion

by Dolly the Sheep | Jun 29, 2026 | Promotion

Gene Delivery 101: Comparing Viral and Non-Viral Vectors

Gene Delivery 101: Comparing Viral and Non-Viral Vectors

by Dolly the Sheep | Jun 26, 2026 | Cancer, CGT Research, Immunology, Molecular, Stem Cell

Gene Delivery 101: Comparing Viral and Non-Viral Vectors In the recent blog post titled “Gene Delivery 101: Comparing Viral and Non-Viral Vectors,” OriGene introduced the evolving landscape of gene delivery systems, highlighting how researchers must...
Cracking the Code of Skin Cancer Progression with VitroGel® Hydrogel Matrix

Cracking the Code of Skin Cancer Progression with VitroGel® Hydrogel Matrix

by Dolly the Sheep | Jun 25, 2026 | Cancer, Disease Modelling, Immunology, Neurology, Organoids, Stem Cell, Tissue Engineering

RESEARCH HIGHLIGHTS FROM THEWELL BIOSCIENCE Cracking the Code of Skin Cancer Progression with VitroGel® Hydrogel Matrix In the recent blog post titled “Cracking the Code of Skin Cancer Progression with VitroGel® Hydrogel Matrix”, TheWell Bioscience...
IL-23: A Key Target for the Treatment of Immune-Mediated Inflammatory Diseases

IL-23: A Key Target for the Treatment of Immune-Mediated Inflammatory Diseases

by Dolly the Sheep | Jun 25, 2026 | Cancer, CGT Research, Drug Discovery, Immunology

ARTICLE FROM KACTUS IL-23: A Key Target for the Treatment of Immune-Mediated Inflammatory Diseases In KACTUS ’s recent feature, Lauren He from KACTUS introduced a comprehensive overview of Interleukin-23 (IL-23) and its role in driving immune-mediated inflammatory...
Translational Continuity: Why Drug Programs Fail Early

Translational Continuity: Why Drug Programs Fail Early

by Dolly the Sheep | Jun 25, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies

ARTICLE BY BIO X CELL Translational Continuity: Why Drug Programs Fail Early In a recent blog post titled “Translational Continuity: Why Drug Programs Fail Early,” Bio X Cell  introduced insights into why over 90% of drug candidates fail during clinical...
Page 2 of 85«12345...102030...»Last »

UNIT 1107, 11/F, ONE MIDTOWN, 11 HOI SHING ROAD, TSUEN WAN, HONG KONG

  • Follow
  • Follow

MENU

  • HOME
  • SUPPLIERS
  • APPLICATIONS
  • BLOG
  • ABOUT
  • CONTACT

SUPPORT

  • TECHNICAL SUPPORT
  • CONTACT US

POLICIES

  • RETURNS & REFUND
  • SHIPPING
  • WEBSITE T&C
  • SALES T&C
  • LEGAL NOTICE
  • PRIVACY POLICY

©2026 LAB-A-PORTER LIMITED, and/or its affiliates. All Rights Reserved.